Helen Xun Hou - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wang YH, Lin CC, Yao CY, Hsu CL, Hou HA, Tsai CH, Chou WC, Tien HF. A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients. Blood Advances. 4: 644-654. PMID 32078680 DOI: 10.1182/bloodadvances.2019001185  0.32
2020 Wang YW, Tsai CH, Lin CC, Tien FM, Chen YW, Lin HY, Yao M, Lin YC, Lin CT, Cheng CL, Tang JL, Chou WC, Hou HA, Tien HF. Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax. Annals of Hematology. PMID 31965269 DOI: 10.1007/s00277-020-03911-z  0.32
2019 McGraw KL, Cheng CH, Chen YA, Hou HA, Nilsson B, Genovese G, Cluzeau T, Pellagatti A, Przychodzen BP, Mallo M, Arenillas L, Mohamedali A, Adès L, Sallman DA, Padron E, et al. Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis. Blood Advances. 3: 3579-3589. PMID 31738830 DOI: 10.1182/bloodadvances.2019000922  0.32
2019 Hsu YC, Chen TC, Lin CC, Yuan CT, Hsu CL, Hou HA, Kao CJ, Chuang PH, Chen YR, Chou WC, Tien HF. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials. Blood Advances. 3: 2355-2367. PMID 31395598 DOI: 10.1182/bloodadvances.2019000391  0.32
2019 Huang HH, Chen FY, Chou WC, Hou HA, Ko BS, Lin CT, Tang JL, Li CC, Yao M, Tsay W, Hsu SC, Wu SJ, Chen CY, Huang SY, Tseng MH, et al. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. Bmc Cancer. 19: 617. PMID 31234830 DOI: 10.1186/s12885-019-5822-y  0.32
2019 Liu JH, Liao XW, Chen CH, Yao M, Li CC, Lin CT, Tsai CH, Chou WC, Hou HA, Huang SY, Wu SJ, Chen YC, Tien HF, Tang JL, Ko BS. Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study. British Journal of Haematology. PMID 30919947 DOI: 10.1111/bjh.15884  0.32
2019 Tsai CH, Yao CY, Tien FM, Tang JL, Kuo YY, Chiu YC, Lin CC, Tseng MH, Peng YL, Liu MC, Liu CW, Yao M, Lin LI, Chou WC, Chen CY, ... Hou HA, et al. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. Ebiomedicine. PMID 30662003 DOI: 10.1016/j.ebiom.2019.01.022  0.32
2019 Christen F, Hoyer K, Yoshida K, Hou HA, Waldhueter N, Heuser M, Hills RK, Chan W, Hablesreiter R, Blau O, Ochi Y, Klement P, Chou WC, Blau IW, Tang JL, et al. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. Blood. PMID 30610028 DOI: 10.1182/blood-2018-05-852822  0.32
2018 Ko BS, Wang YF, Li JL, Li CC, Weng PF, Hsu SC, Hou HA, Huang HH, Yao M, Lin CT, Liu JH, Tsai CH, Huang TC, Wu SJ, Huang SY, et al. Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome. Ebiomedicine. PMID 30361063 DOI: 10.1016/j.ebiom.2018.10.042  0.32
2018 Tien FM, Hou HA, Tsai CH, Tang JL, Chiu YC, Chen CY, Kuo YY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Lin CT, Wu SJ, et al. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia. Blood Cancer Journal. 8: 87. PMID 30190467 DOI: 10.1038/s41408-018-0123-2  0.32
2018 Yang YT, Chiu YC, Kao CJ, Hou HA, Lin CC, Tsai CH, Tseng MH, Chou WC, Tien HF. The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome. Blood Cancer Journal. 8: 78. PMID 30104611 DOI: 10.1038/s41408-018-0115-2  0.32
2018 Tefferi A, Gangat N, Mudireddy M, Lasho TL, Finke C, Begna KH, Elliott MA, Al-Kali A, Litzow MR, Hook CC, Wolanskyj AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, ... ... Hou HA, et al. Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information. Mayo Clinic Proceedings. PMID 29866419 DOI: 10.1016/j.mayocp.2018.04.013  0.32
2018 Tien FM, Hou HA, Tang JL, Kuo YY, Chen CY, Tsai CH, Yao M, Lin CT, Li CC, Huang SY, Ko BS, Hsu SC, Wu SJ, Liu JH, Chou SC, et al. Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA. Haematologica. PMID 29773598 DOI: 10.3324/haematol.2018.189043  0.32
2018 Nagase R, Inoue D, Pastore A, Fujino T, Hou HA, Yamasaki N, Goyama S, Saika M, Kanai A, Sera Y, Horikawa S, Ota Y, Asada S, Hayashi Y, Kawabata KC, et al. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation. The Journal of Experimental Medicine. PMID 29643185 DOI: 10.1084/jem.20171151  0.32
2018 Tien FM, Hou HA, Tsai CH, Tang JL, Chen CY, Kuo YY, Li CC, Lin CT, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Tseng MH, et al. Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients. European Journal of Haematology. PMID 29624746 DOI: 10.1111/ejh.13073  0.32
2018 Lin ME, Hou HA, Tsai CH, Wu SJ, Kuo YY, Tseng MH, Liu MC, Liu CW, Chou WC, Chen CY, Tang JL, Yao M, Li CC, Huang SY, Ko BS, et al. Dynamics ofmutation and prognostic relevance in patients with primary myelodysplastic syndrome. Clinical Epigenetics. 10: 42. PMID 29619119 DOI: 10.1186/s13148-018-0476-1  0.32
2018 Hou HA, Tsai CH, Lin CC, Chou WC, Kuo YY, Liu CY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Yao M, Tang JL, Tien HF. Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. Blood Cancer Journal. 8: 39. PMID 29618722 DOI: 10.1038/s41408-018-0074-7  0.32
2017 Yao CY, Chen CH, Huang HH, Hou HA, Lin CC, Tseng MH, Kao CJ, Lu TP, Chou WC, Tien HF. A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes. Blood Advances. 1: 1505-1516. PMID 29296792 DOI: 10.1182/bloodadvances.2017008284  0.32
2017 Tsai CH, Hou HA, Tang JL, Kuo YY, Chiu YC, Lin CC, Liu CY, Tseng MH, Lin TY, Liu MC, Liu CW, Lin LI, Yao M, Li CC, Huang SY, et al. Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia. Blood Cancer Journal. 7: 663. PMID 29288251 DOI: 10.1038/s41408-017-0022-y  0.32
2017 Lee SH, Chiu YC, Li YH, Lin CC, Hou HA, Chou WC, Tien HF. High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia. Oncotarget. 8: 72250-72259. PMID 29069784 DOI: 10.18632/oncotarget.19706  0.32
2017 Hsu YC, Chiu YC, Lin CC, Kuo YY, Hou HA, Tzeng YS, Kao CJ, Chuang PH, Tseng MH, Hsiao TH, Chou WC, Tien HF. The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model. Journal of Hematology & Oncology. 10: 139. PMID 28697759 DOI: 10.1186/s13045-017-0508-x  0.32
2017 Lin CC, Hsu YC, Li YH, Kuo YY, Hou HA, Lan KH, Chen TC, Tzeng YS, Kuo YY, Kao CJ, Chuang PH, Tseng MH, Chiu YC, Chou WC, Tien HF. Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia. Haematologica. PMID 28341738 DOI: 10.3324/haematol.2016.161257  0.32
2016 Wei TW, Wu PY, Wu TJ, Hou HA, Chou WC, Teng CJ, Lin CR, Chen JM, Lin TY, Su HC, Huang CF, Yu CR, Hsu SL, Tien HF, Tsai MD. Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA. Cancer Research. PMID 28069801 DOI: 10.1158/0008-5472.CAN-16-1004  0.32
2016 Chiang Y, Tsai CH, Kuo SH, Liu CY, Yao M, Li CC, Huang SY, Ko BS, Lin CT, Hou HA, Chou WC, Liu JH, Lin CC, Wu SJ, Hsu SC, et al. Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation. Scientific Reports. 6: 36730. PMID 27830767 DOI: 10.1038/srep36730  0.32
2016 Huang SY, Lin HH, Lin CW, Li CC, Yao M, Tang JL, Hou HA, Tsay W, Chou SJ, Cheng CL, Tien HF. Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma. Oncotarget. PMID 27566569 DOI: 10.18632/oncotarget.11519  0.32
2016 Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, Chiang YC, Liu MC, Liu CW, Kuo YY, Wu SJ, Liao XW, Lin CT, Ko BS, Chen CY, et al. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS). Oncotarget. PMID 27527853 DOI: 10.18632/oncotarget.11050  0.32
2016 Lu JW, Wang AN, Liao HA, Chen CY, Hou HA, Hu CY, Tien HF, Ou DL, Lin LI. Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD). Cancer Letters. PMID 27060207 DOI: 10.1016/j.canlet.2016.04.004  0.32
2016 Hou HA, Liu CY, Kuo YY, Chou WC, Tsai CH, Lin CC, Lin LI, Tseng MH, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, Li CC, Huang SY, et al. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget. PMID 26812887 DOI: 10.18632/oncotarget.7000  0.32
2016 Hou HA, Tien HF. Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility Expert Review of Hematology. 1-23. DOI: 10.1586/17474086.2016.1144469  0.32
2015 Chuang MK, Chiu YC, Chou WC, Hou HA, Tseng MH, Kuo YY, Chen Y, Chuang EY, Tien HF. An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype. Oncotarget. PMID 26517675 DOI: 10.18632/oncotarget.5390  0.32
2015 Huang SY, Lin HH, Yao M, Tang JL, Wu SJ, Hou HA, Chou WC, Chou SC, Hsu SC, Ko BS, Lu HY, Tsay W, Tien HF. Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study. Plos One. 10: e0137552. PMID 26379028 DOI: 10.1371/journal.pone.0137552  0.32
2015 Chiu YC, Tsai MH, Chou WC, Liu YC, Kuo YY, Hou HA, Lu TP, Lai LC, Chen Y, Tien HF, Chuang EY. Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia. Leukemia. PMID 26376228 DOI: 10.1038/leu.2015.253  0.32
2015 Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, Lin CT, Li CC, Wu SJ, Hou HA, Chou WC, Huang SY, Tsay W, Chen YC, Chen YC, et al. High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan. Plos One. 10: e0128410. PMID 26061179 DOI: 10.1371/journal.pone.0128410  0.32
2015 Cheng CL, Li CC, Hou HA, Fang WQ, Chang CH, Lin CT, Tang JL, Chou WC, Chen CY, Yao M, Huang SY, Ko BS, Wu SJ, Tsay W, Tien HF. Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. Bmc Cancer. 15: 344. PMID 25934556 DOI: 10.1186/s12885-015-1376-9  0.32
2015 Chen YK, Hou HA, Tang JL, Jhuang JY, Lai YJ, Lee MC, Kuo YY, Chou WC, Liu CY, Lin CW, Chuang SS, Chen CY, Tseng MH, Huang CF, Chiang YC, et al. Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia. Plos One. 10: e0119831. PMID 25794001 DOI: 10.1371/journal.pone.0119831  0.32
2015 Inoue D, Kitaura J, Matsui H, Hou HA, Chou WC, Nagamachi A, Kawabata KC, Togami K, Nagase R, Horikawa S, Saika M, Micol JB, Hayashi Y, Harada Y, Harada H, et al. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS. Leukemia. 29: 847-57. PMID 25306901 DOI: 10.1038/leu.2014.301  0.32
2015 Hou HA, Lin YC, Kuo YY, Chou WC, Lin CC, Liu CY, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, et al. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution. Annals of Hematology. 94: 211-21. PMID 25241285 DOI: 10.1007/s00277-014-2208-8  0.32
2015 Liu SH, Hou HY, Shu CM. Thermal hazard evaluation of the autocatalytic reaction of benzoyl peroxide using DSC and TAM III Thermochimica Acta. 605: 68-76. DOI: 10.1016/j.tca.2015.02.008  0.32
2015 Liu SH, Shu CM, Hou HY. Applications of thermal hazard analyses on process safety assessments Journal of Loss Prevention in the Process Industries. 33: 59-69. DOI: 10.1016/j.jlp.2014.11.007  0.32
2015 Wang L, Wu J, Chen Y, Wang X, Zhou R, Chen S, Guo Q, Hou H, Song Y. Hollow Nitrogen-doped Fe3O4/Carbon Nanocages with Hierarchical Porosities as Anode Materials for Lithium-ion Batteries Electrochimica Acta. 186: 50-57. DOI: 10.1016/j.electacta.2015.10.134  0.32
2015 Liu SH, Chen YC, Hou HY. Thermal runaway hazard studies for ABVN mixed with acids or alkalines by DSC, TAM III, and VSP2 Journal of Thermal Analysis and Calorimetry. 122: 1107-1116. DOI: 10.1007/s10973-015-4789-4  0.32
2014 Chou SC, Tang JL, Hou HA, Chou WC, Hu FC, Chen CY, Yao M, Ko BS, Huang SY, Tsay W, Chen YC, Tien HF. Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations. Leukemia Research. 38: 1278-84. PMID 25260824 DOI: 10.1016/j.leukres.2014.08.012  0.32
2014 Kuo YY, Hou HA, Chen YK, Li LY, Chen PH, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Chou WC, Liu CY, Tang JL, Yao M, Tien HF. The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression. Haematologica. 99: 1799-807. PMID 25193961 DOI: 10.3324/haematol.2014.107821  0.32
2014 Hsiao LT, Tien HF, Kuo CY, Wu JH, Hou HA, Wang MC, Liu CY, Chen PM, Chiou TJ. Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Hematological Oncology. PMID 25111959 DOI: 10.1002/hon.2161  0.32
2014 Yang YT, Hou HA, Liu CY, Lin CC, Chou WC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Li CC, Kuo YY, Huang SY, Ko BS, Chen CY, et al. IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients. American Journal of Hematology. 89: E142-9. PMID 24845799 DOI: 10.1002/ajh.23765  0.32
2014 Lin CC, Hou HA, Chou WC, Kuo YY, Wu SJ, Liu CY, Chen CY, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, et al. SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution. American Journal of Hematology. 89: E109-15. PMID 24723457 DOI: 10.1002/ajh.23734  0.32
2014 Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI. MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia. Leukemia Research. 38: 625-31. PMID 24703161 DOI: 10.1016/j.leukres.2014.03.008  0.32
2014 Huang SY, Lin CW, Lin HH, Yao M, Tang JL, Wu SJ, Chen YC, Lu HY, Hou HA, Chen CY, Chou WC, Tsay W, Chou SJ, Tien HF. Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. Annals of Hematology. 93: 1371-80. PMID 24687382 DOI: 10.1007/s00277-014-2063-7  0.32
2014 Hou HA, Kuo YY, Tang JL, Chou WC, Yao M, Lai YJ, Lin CC, Chen CY, Liu CY, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, et al. Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression. American Journal of Hematology. 89: 181-6. PMID 24127063 DOI: 10.1002/ajh.23611  0.32
2014 Lin CC, Hou HA, Chou WC, Kuo YY, Liu CY, Chen CY, Lai YJ, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, et al. IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. American Journal of Hematology. 89: 137-44. PMID 24115220 DOI: 10.1002/ajh.23596  0.32
2014 Lee MC, Kuo YY, Chou WC, Hou HA, Hsiao M, Tien HF. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells. Journal of Leukocyte Biology. 95: 105-15. PMID 24018353 DOI: 10.1189/jlb.0912475  0.32
2014 Liu SH, Yu YP, Lin YC, Weng SY, Hsieh TF, Hou HY. Complex thermal evaluation for 2,2′-azobis(isobutyronitrile) by non-isothermal and isothermal kinetic analysis methods Journal of Thermal Analysis and Calorimetry. 116: 1361-1367. DOI: 10.1007/s10973-013-3632-z  0.32
2013 Wu SJ, Tang JL, Lin CT, Kuo YY, Li LY, Tseng MH, Huang CF, Lai YJ, Lee FY, Liu MC, Liu CW, Hou HA, Chen CY, Chou WC, Yao M, et al. Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression. American Journal of Hematology. 88: E277-82. PMID 23861105 DOI: 10.1002/ajh.23541  0.32
2013 Cheng CL, Hou HA, Lee MC, Liu CY, Jhuang JY, Lai YJ, Lin CW, Chen HY, Liu FT, Chou WC, Chen CY, Tang JL, Yao M, Huang SY, Ko BS, et al. Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia. Blood. 121: 3172-80. PMID 23449638 DOI: 10.1182/blood-2012-07-443762  0.32
2013 Wu SJ, Lin CT, Huang SY, Lee FY, Liu MC, Hou HA, Chen CY, Ko BS, Chou WC, Yao M, Tang JL, Tsay W, Tien HF. Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence--clinical implication and comparison between the West and the East. Annals of Hematology. 92: 799-806. PMID 23417757 DOI: 10.1007/s00277-013-1700-x  0.32
2013 Hou HY, Chen JW, Weng SY, Lin YC, Shu CM. Effects of thermal runaway hazard for three organic peroxides conducted by acids and alkalines with DSC, VSP2, and TAM III Thermochimica Acta. 566: 226-232. DOI: 10.1016/j.tca.2013.05.029  0.32
2013 Su CH, Hou HY, Wu CW. Analysis on practical thermal responsiveness of the glass bulb sprinklers Procedia Engineering. 62: 844-851. DOI: 10.1016/j.proeng.2013.08.134  0.32
2012 Chou SH, Ko BS, Chiou JS, Hsu YC, Tsai MH, Chiu YC, Yu IS, Lin SW, Hou HA, Kuo YY, Lin HM, Wu MF, Chou WC, Tien HF. A knock-in Npm1 mutation in mice results in myeloproliferation and implies a perturbation in hematopoietic microenvironment. Plos One. 7: e49769. PMID 23226219 DOI: 10.1371/journal.pone.0049769  0.32
2012 Wu SJ, Kuo YY, Hou HA, Li LY, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Lin CT, Chen CY, Chou WC, Yao M, Huang SY, Ko BS, et al. The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution. Blood. 120: 3106-11. PMID 22932795 DOI: 10.1182/blood-2012-02-412296  0.32
2012 Hou HA, Kuo YY, Liu CY, Chou WC, Lee MC, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, et al. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood. 119: 559-68. PMID 22077061 DOI: 10.1182/blood-2011-07-369934  0.32
2012 Hou HY, Su CH, Shu CM. Thermal risk analysis of cumene hydroperoxide in the presence of alkaline catalysts Journal of Loss Prevention in the Process Industries. 25: 176-180. DOI: 10.1016/j.jlp.2011.09.001  0.32
2012 Tsai LC, Chen JW, Hou HY, Liu SH, Shu CM. Exothermic behaviors in decomposition of three solid organic peroxides by DSC and VSP2 Journal of Thermal Analysis and Calorimetry. 109: 1303-1309. DOI: 10.1007/s10973-012-2520-2  0.32
2011 Chou WC, Chou SC, Liu CY, Chen CY, Hou HA, Kuo YY, Lee MC, Ko BS, Tang JL, Yao M, Tsay W, Wu SJ, Huang SY, Hsu SC, Chen YC, et al. TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. Blood. 118: 3803-10. PMID 21828143 DOI: 10.1182/blood-2011-02-339747  0.32
2011 Lin TC, Jiang SS, Chou WC, Hou HA, Lin YM, Chang CL, Hsu CA, Tien HF, Lin LI. Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile. The Journal of Molecular Diagnostics : Jmd. 13: 514-9. PMID 21723418 DOI: 10.1016/j.jmoldx.2011.05.002  0.32
2011 Chen BB, Hsu CY, Yu CW, Hou HA, Liu CY, Wei SY, Chou WC, Tien HF, Shih TT. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission. Radiology. 258: 821-31. PMID 21212370 DOI: 10.1148/radiol.10100995  0.32
2010 Chou WC, Huang HH, Hou HA, Chen CY, Tang JL, Yao M, Tsay W, Ko BS, Wu SJ, Huang SY, Hsu SC, Chen YC, Huang YN, Chang YC, Lee FY, et al. Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations. Blood. 116: 4086-94. PMID 20693432 DOI: 10.1182/blood-2010-05-283291  0.32
2010 Hou HA, Huang TC, Lin LI, Liu CY, Chen CY, Chou WC, Tang JL, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Yao M, Huang SY, Ko BS, et al. WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system. Blood. 115: 5222-31. PMID 20368469 DOI: 10.1182/blood-2009-12-259390  0.32
2010 Hou HA, Shih TT, Liu CY, Chen BB, Tang JL, Yao M, Huang SY, Chou WC, Hsu CY, Tien HF. Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia. Haematologica. 95: 1420-4. PMID 20220062 DOI: 10.3324/haematol.2009.019364  0.32
2010 Chou WC, Hou HA, Chen CY, Tang JL, Yao M, Tsay W, Ko BS, Wu SJ, Huang SY, Hsu SC, Chen YC, Huang YN, Chang YC, Lee FY, Liu MC, et al. Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation. Blood. 115: 2749-54. PMID 20097881 DOI: 10.1182/blood-2009-11-253070  0.32
2010 Huang CC, Peng JJ, Wu SH, Hou HY, You ML, Shu CM. Effects of cumene hydroperoxide on phenol and acetone manufacturing by DSC and VSP2 Journal of Thermal Analysis and Calorimetry. 102: 579-585. DOI: 10.1007/s10973-010-0953-z  0.32
2009 Tang JL, Hou HA, Chen CY, Liu CY, Chou WC, Tseng MH, Huang CF, Lee FY, Liu MC, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 114: 5352-61. PMID 19808697 DOI: 10.1182/blood-2009-05-223784  0.32
2009 Shih TT, Hou HA, Liu CY, Chen BB, Tang JL, Chen HY, Wei SY, Yao M, Huang SY, Chou WC, Hsu SC, Tsay W, Yu CW, Hsu CY, Tien HF, et al. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood. 113: 3161-7. PMID 18988863 DOI: 10.1182/blood-2008-08-173104  0.32
2009 Chou YP, Wu SH, Shu CM, Hou HY. Reaction hazard of cumene hydroperoxide with sodium hydroxide by isothermal calorimetry Safety, Reliability and Risk Analysis: Theory, Methods and Applications - Proceedings of the Joint Esrel and Sra-Europe Conference. 3: 2405-2408.  0.32
2008 Hou HA, Chou WC, Lin LI, Tang JL, Tseng MH, Huang CF, Yao M, Chen CY, Tsay W, Tien HF. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leukemia Research. 32: 904-12. PMID 17904634 DOI: 10.1016/j.leukres.2007.08.010  0.32
2008 Hou HY, Shu CM, Tsai TL. Reactions of cumene hydroperoxide mixed with sodium hydroxide Journal of Hazardous Materials. 152: 1214-1219. PMID 17889997 DOI: 10.1016/j.jhazmat.2007.07.118  0.32
Show low-probability matches.